{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:21:08Z","timestamp":1784650868271,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00417-010-1470-2","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T06:08:16Z","timestamp":1282025296000},"page":"183-192","source":"Crossref","is-referenced-by-count":78,"title":["Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion"],"prefix":"10.1007","volume":"249","author":[{"name":"Retinal Vein Occlusion Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine B.","family":"Jaissle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Szurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Feltgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Pielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matus","family":"Rehak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Spital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,18]]},"reference":[{"key":"1470_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","volume":"98","author":"The Branch Vein Occlusion Study Group","year":"1984","unstructured":"The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271\u2013282","journal-title":"Am J Ophthalmol"},{"key":"1470_CR2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","volume":"127","author":"The SCORE Study Research Group","year":"2009","unstructured":"The SCORE Study Research Group (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol 127:1115\u20131128","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"1470_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajo.2009.08.005","volume":"149","author":"J Wroblewski","year":"2010","unstructured":"Wroblewski JJ, Wells JA 3rd, Gonzales CR (2010) Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion. Am J Ophthalmol 149(1):147\u2013154","journal-title":"Am J Ophthalmol"},{"key":"1470_CR4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00006982-200406000-00002","volume":"24","author":"MS Mandelcorn","year":"2004","unstructured":"Mandelcorn MS, Nrusimhadevara RK (2004) Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina 24:348\u2013355","journal-title":"Retina"},{"key":"1470_CR5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00006982-200212000-00009","volume":"22","author":"U Mester","year":"2002","unstructured":"Mester U, Dillinger P (2002) Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 22:740\u2013746","journal-title":"Retina"},{"key":"1470_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archopht.116.1.43","volume":"116","author":"S Fekrat","year":"1998","unstructured":"Fekrat S, Goldberg MF, Finkelstein D (1998) Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol 116:43\u201352","journal-title":"Arch Ophthalmol"},{"key":"1470_CR7","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/S0161-6420(01)00875-2","volume":"108","author":"JN Weiss","year":"2001","unstructured":"Weiss JN, Bynoe LA (2001) Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 108:2249\u20132257","journal-title":"Ophthalmology"},{"key":"1470_CR8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.eye.6702498","volume":"22","author":"H Noma","year":"2008","unstructured":"Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22:42\u201348","journal-title":"Eye"},{"key":"1470_CR9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1167\/iovs.08-2510","volume":"50","author":"M Funk","year":"2009","unstructured":"Funk M, Kriechbaum K, Prager F, Benesch T, Georgopoulos M, Zlabinger GJ, Schmidt-Erfurth U (2009) Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with -bevacizumab. Investig Ophthalmol Vis Sci 50:1025\u20131032","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1470_CR10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajo.2008.05.036","volume":"146","author":"TU Krohne","year":"2008","unstructured":"Krohne TU, Eter N, Holz FG, Meyer CH (2008) Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol 146:508\u2013512","journal-title":"Am J Ophthalmol"},{"key":"1470_CR11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IAE.0b013e318030e77e","volume":"27","author":"MD Rabena","year":"2007","unstructured":"Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL (2007) Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 27:419\u2013425","journal-title":"Retina"},{"key":"1470_CR12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000183844","volume":"223","author":"F Rensch","year":"2008","unstructured":"Rensch F, Jonas JB, Spandau UH (2008) Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion. Ophthalmologica 223:124\u2013127","journal-title":"Ophthalmologica"},{"key":"1470_CR13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bjo.2008.141085","volume":"93","author":"F Prager","year":"2009","unstructured":"Prager F, Michels S, Kriechbaum K, Georgopoulos M, Funk M, Geitzenauer W, Polak K, Schmidt-Erfurth U (2009) Intravitreal bevacizumab (Avastin) for macular edema secondary to retinal vein occlusion - twelve-month results of a prospective clinical trial. Br J Ophthalmol 93:452\u2013526","journal-title":"Br J Ophthalmol"},{"key":"1470_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00417-008-0916-2","volume":"247","author":"GB Jaissle","year":"2009","unstructured":"Jaissle GB, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt KU, Szurman P (2009) One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 247:27\u201333","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1470_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/bjo.2007.123513","volume":"92","author":"TC Kreutzer","year":"2008","unstructured":"Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R, Kunze C, Haritoglou C, Kampik A, Priglinger S (2008) Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 92:351\u2013355","journal-title":"Br J Ophthalmol"},{"key":"1470_CR16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bjo.2007.127282","volume":"92","author":"K Kriechbaum","year":"2008","unstructured":"Kriechbaum K, Michels S, Prager F, Georgopoulos M, Funk M, Geitzenauer W, Schmidt-Erfurth U (2008) Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 92:518\u2013522","journal-title":"Br J Ophthalmol"},{"key":"1470_CR17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00417-007-0569-6","volume":"245","author":"A Stahl","year":"2007","unstructured":"Stahl A, Agostini H, Hansen LL, Feltgen N (2007) Bevacizumab in retinal vein occlusion\u2014results of a prospective case series. Graefes Arch Clin Exp Ophthalmol 245:1429\u20131436","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1470_CR18","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/IAE.0b013e3181aa8e20","volume":"29","author":"M Kondo","year":"2009","unstructured":"Kondo M, Kondo N, Ito Y, Kachi S, Kikuchi M, Yasuma TR, Ota I, Kensaku M, Terasaki H (2009) Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12\u00a0months and multiple regression analysis. Retina 29:1242\u20131248","journal-title":"Retina"},{"key":"1470_CR19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-2005-858231","volume":"222","author":"GB Jaissle","year":"2005","unstructured":"Jaissle GB, Szurman P, Bartz-Schmidt K (2005) Recommendation for the procedure of intravitreal injections of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Klin Monatsbl Augenheilkd 222:390\u2013395","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1470_CR20","first-page":"25","volume-title":"Intravitreale Pharmakotherapie. Moderne Medikamente und ihre Anwendung am Auge","author":"GB Jaissle","year":"2008","unstructured":"Jaissle GB, Karl I, Bartz-Schmidt KU (2008) Einwilligung und Besonderheiten der Aufkl\u00e4rung im Off-Label-Bereich. In: Bartz-Schmidt KU, Ziemssen F (eds) Intravitreale Pharmakotherapie. Moderne Medikamente und ihre Anwendung am Auge. Schattauer, Stuttgart, pp 25\u201329"},{"key":"1470_CR21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ophtha.2005.10.005","volume":"113","author":"SR Sadda","year":"2006","unstructured":"Sadda SR, Wu Z, Walsh AC, Richine L, Dougall J, Cortez R, LaBree LD (2006) Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 113:285\u2013293","journal-title":"Ophthalmology"},{"key":"1470_CR22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00347-007-1639-1","volume":"105","author":"M Bolz","year":"2008","unstructured":"Bolz M, Ritter M, Polak K, Bolz M, Ritter M, Polak K, Ahlers C, Hirn C, Pr\u00fcnte C, Golbaz I, Benesch T, Schmidt-Erfurth U (2008) The role of stratus OCT in anti-VEGF therapy: qualitative and quantitative assessment of neovascular AMD. Ophthalmologe 105:650\u2013655","journal-title":"Ophthalmologe"},{"key":"1470_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archopht.124.2.193","volume":"124","author":"A Chan","year":"2006","unstructured":"Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS (2006) Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography. Arch Ophthalmol 124:193\u2013198","journal-title":"Arch Ophthalmol"},{"key":"1470_CR24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0161-6420(96)30653-2","volume":"103","author":"A Glacet-Bernard","year":"1996","unstructured":"Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM (1996) Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103:551\u2013560","journal-title":"Ophthalmology"},{"key":"1470_CR25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00417-008-0866-8","volume":"246","author":"EJ Chung","year":"2008","unstructured":"Chung EJ, Hong YT, Lee SC, Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ (2008) Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246:1241\u20131247","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00417-010-1470-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T08:44:56Z","timestamp":1497861896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1470-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,18]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1470-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,18]]}}}